GlassScriptPhysician profile
Joanne M Larow
NPI 1538230990
$1,309.05
in general payments reported to CMS, 2019-2025
11 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $222 · 2023: $735 · 2024: $167 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $953.93 |
| Education | $133.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $374.49 | 2022-2025 | Ilumya, Winlevi, Absorica Ld |
| Ucb, INC. | $171.70 | 2022-2024 | Cimzia, Bimzelx |
| Abbvie INC. | $146.24 | 2022-2025 | |
| Genzyme Corporation | $127.56 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $122.91 | 2022-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $120.79 | 2023-2024 | Olumiant, Taltz |
| Pfizer INC. | $94.99 | 2023 | |
| Incyte Corporation | $46.53 | 2022-2025 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $42.62 | 2023 | Sotyktu |
| Smith+Nephew, INC. | $41.48 | 2024 | Grafix Pl |
| Biofrontera INC. | $19.74 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Larow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.